By Admin at 12 Apr 2017
Researchers have now gained greater insights into how vitamin C may be harnessed to kill cancer cells, courtesy of a new study co-funded by Gateway for Cancer Research.
By Admin at 4 Apr 2017
Each year, around 70,000 young adults are diagnosed with cancer in the United States, which accounts for five percent of cancer diagnoses in the country. This statistic is six times higher than the number of cancers diagnosed in children, age 14 and below.
By Admin at 30 Mar 2017
Part of the challenge of winning the war against cancer lies in treating the disease in its later stages — a point at which many cancers become hard, if not impossible, to eliminate. Cancer interception may change that by targeting cancer at its earliest stages, in some cases even before it starts.
By Admin at 29 Mar 2017
In honor of Kidney Cancer Awareness Month, we are spotlighting the courageous journey of Kenneth Monarrez, Gateway Associates Board member, who sought out a clinical trail to ultimately beat his cancer.
By Admin at 14 Mar 2017
The usual treatment for metastatic colorectal cancer includes chemotherapy, radiation and surgical resection. Unfortunately, the average survival rate has been only 20-24 months. In a Gateway-funded clinical trial led by Dr. Edward Lin, a survival rate of approximately 94+ months was achieved using a new approach called ADAPT – Activate tumor from Dormancy And Potentiate its Targeting.